|
MechanismMuc18 inhibitors |
|
|
|
|
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Wenbli Therapeutics, Inc.
0 Patents (Medical) associated with Wenbli Therapeutics, Inc.
100 Deals associated with Wenbli Therapeutics, Inc.
100 Translational Medicine associated with Wenbli Therapeutics, Inc.